The deletion of Kdm6a in mouse CD4+ T cells diminished neuroinflammation and protected mice from MS-like symptoms in the EAE model, due to a defect in the differentiation of pathogenic T lymphocytes [41]. Here, KDM6A is linked to myeloid sarcoma.